Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The Effect of taVNS and Upper GI Motility

NCT: NCT07632378 · RECRUITING

NCT IDNCT07632378
StatusRECRUITING
Start Date2025-02-25
Completion2026-06
SponsorDaniel Keszthelyi (OTHER)
First posted
Last updated

Brief Summary

This single-center randomized controlled cross-over trial aims to investigate the effect of transcutaneous auricular vagus nerve stimulation on upper gastrointestinal motility in healthy individuals. The primary aim of this study is to assess the impact of tVNS on gut motor function, with regards to its potential to induce phase III contractions in the upper GI tract. Secondary objectives include: * To study the effect of tVNS on other parameters characterizing upper GI motility such as the number of duodenal phase III contractions, gastric and duodenal phase MMCs, amplitude of antral contractions and motility index * To study the effect of tVNS on plasma levels of motilin and PP * To evaluate the effect of tVNS on parameters related to autonomic outflow, using a Shimmer3 GSR Sensor for heart rate variability and skin conductance. * To compare the results of the measurements of antroduodenal manometry with measurements of Gastric Alimetry Participants will undergo tVNS (applied to the cymba conchae of the left ear) alternating with sham stimulation (using a non-conducting electrode) in a blinded, pre-randomized fashion, using two 4-hour blocks during an 8-hour fasted antroduodenal manometry recording period. Optionally, participants may simultaneously also undergo body surface gastric mapping using the Gastric Alimetry system.

Frequently Asked Questions

What is The Effect of taVNS and Upper GI Motility?

The Effect of taVNS and Upper GI Motility is a clinical trial registered under NCT07632378. Current status: RECRUITING.

What is the status of NCT07632378?

The current status of NCT07632378 (The Effect of taVNS and Upper GI Motility) is: RECRUITING.

When did The Effect of taVNS and Upper GI Motility start?

The Effect of taVNS and Upper GI Motility started on 2025-02-25.

Related Devices

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.